vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Identiv, Inc. (INVE). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.2M, roughly 1.5× Identiv, Inc.). Identiv, Inc. runs the higher net margin — -60.3% vs -234.3%, a 173.9% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -7.9%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -3.8%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Identiv is a publicly traded Internet of Things technology company listed on the Nasdaq stock market.
FHTX vs INVE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $6.2M |
| Net Profit | $-21.7M | $-3.7M |
| Gross Margin | — | 18.1% |
| Operating Margin | -258.2% | -76.4% |
| Net Margin | -234.3% | -60.3% |
| Revenue YoY | 223.8% | -7.9% |
| Net Profit YoY | -11.1% | -948.2% |
| EPS (diluted) | $-0.35 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $6.2M | ||
| Q3 25 | $8.2M | $5.0M | ||
| Q2 25 | $7.6M | $5.0M | ||
| Q1 25 | $6.0M | $5.3M | ||
| Q4 24 | $2.9M | $6.7M | ||
| Q3 24 | $7.8M | $6.5M | ||
| Q2 24 | $6.9M | $6.7M | ||
| Q1 24 | $5.0M | $6.7M |
| Q4 25 | $-21.7M | $-3.7M | ||
| Q3 25 | $-15.8M | $-3.5M | ||
| Q2 25 | $-17.9M | $-6.0M | ||
| Q1 25 | $-18.8M | $-4.8M | ||
| Q4 24 | $-19.5M | $-355.0K | ||
| Q3 24 | $-19.1M | $85.9M | ||
| Q2 24 | $-23.0M | $-6.2M | ||
| Q1 24 | $-25.0M | $-4.6M |
| Q4 25 | — | 18.1% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | -9.4% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | -14.9% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -258.2% | -76.4% | ||
| Q3 25 | -226.9% | -111.4% | ||
| Q2 25 | -279.2% | -126.7% | ||
| Q1 25 | -385.0% | -103.8% | ||
| Q4 24 | -840.5% | -98.9% | ||
| Q3 24 | -305.5% | -146.2% | ||
| Q2 24 | -386.6% | -99.7% | ||
| Q1 24 | -558.3% | -76.0% |
| Q4 25 | -234.3% | -60.3% | ||
| Q3 25 | -194.4% | -68.9% | ||
| Q2 25 | -237.3% | -119.9% | ||
| Q1 25 | -316.4% | -90.9% | ||
| Q4 24 | -682.9% | -5.3% | ||
| Q3 24 | -244.9% | 1315.8% | ||
| Q2 24 | -333.6% | -92.2% | ||
| Q1 24 | -495.4% | -68.5% |
| Q4 25 | $-0.35 | $-0.17 | ||
| Q3 25 | $-0.25 | $-0.15 | ||
| Q2 25 | $-0.28 | $-0.26 | ||
| Q1 25 | $-0.30 | $-0.21 | ||
| Q4 24 | $-0.23 | $0.00 | ||
| Q3 24 | $-0.31 | $3.62 | ||
| Q2 24 | $-0.45 | $-0.27 | ||
| Q1 24 | $-0.59 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $128.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $140.7M |
| Total Assets | $198.1M | $151.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $128.6M | ||
| Q3 25 | $89.3M | $126.3M | ||
| Q2 25 | $72.6M | $129.3M | ||
| Q1 25 | $61.0M | $132.4M | ||
| Q4 24 | $55.5M | $135.6M | ||
| Q3 24 | $57.7M | $145.4M | ||
| Q2 24 | $138.9M | $18.4M | ||
| Q1 24 | $79.3M | $21.6M |
| Q4 25 | $-108.5M | $140.7M | ||
| Q3 25 | $-89.7M | $143.7M | ||
| Q2 25 | $-76.7M | $146.4M | ||
| Q1 25 | $-61.7M | $150.5M | ||
| Q4 24 | $-45.5M | $154.1M | ||
| Q3 24 | $-28.3M | $156.7M | ||
| Q2 24 | $-14.3M | $65.1M | ||
| Q1 24 | $-97.5M | $70.2M |
| Q4 25 | $198.1M | $151.3M | ||
| Q3 25 | $205.0M | $151.0M | ||
| Q2 25 | $226.2M | $153.9M | ||
| Q1 25 | $258.7M | $158.7M | ||
| Q4 24 | $284.0M | $163.2M | ||
| Q3 24 | $308.4M | $177.0M | ||
| Q2 24 | $328.6M | $97.8M | ||
| Q1 24 | $255.0M | $101.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $3.0M |
| Free Cash FlowOCF − Capex | — | $2.8M |
| FCF MarginFCF / Revenue | — | 45.8% |
| Capex IntensityCapex / Revenue | 0.0% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $3.0M | ||
| Q3 25 | $-18.9M | $-2.9M | ||
| Q2 25 | $-21.0M | $-3.6M | ||
| Q1 25 | $-24.0M | $-3.3M | ||
| Q4 24 | $-24.5M | $-5.9M | ||
| Q3 24 | $-21.0M | $-7.2M | ||
| Q2 24 | $-25.5M | $-993.0K | ||
| Q1 24 | $-29.3M | $-1.3M |
| Q4 25 | — | $2.8M | ||
| Q3 25 | — | $-3.2M | ||
| Q2 25 | $-21.0M | $-3.8M | ||
| Q1 25 | $-24.0M | $-3.6M | ||
| Q4 24 | $-25.0M | $-6.5M | ||
| Q3 24 | $-21.3M | $-7.7M | ||
| Q2 24 | $-25.6M | $-1.1M | ||
| Q1 24 | $-29.4M | $-1.5M |
| Q4 25 | — | 45.8% | ||
| Q3 25 | — | -64.5% | ||
| Q2 25 | -278.2% | -75.8% | ||
| Q1 25 | -403.2% | -68.0% | ||
| Q4 24 | -875.3% | -97.7% | ||
| Q3 24 | -273.0% | -118.2% | ||
| Q2 24 | -371.0% | -16.7% | ||
| Q1 24 | -583.1% | -23.0% |
| Q4 25 | 0.0% | 3.3% | ||
| Q3 25 | 0.0% | 7.0% | ||
| Q2 25 | 0.3% | 5.0% | ||
| Q1 25 | 0.5% | 5.7% | ||
| Q4 24 | 16.8% | 9.3% | ||
| Q3 24 | 4.0% | 7.7% | ||
| Q2 24 | 0.2% | 2.0% | ||
| Q1 24 | 2.0% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
INVE
| Other | $3.4M | 55% |
| Europe And Middle East | $2.2M | 36% |
| Asia Pacific | $575.0K | 9% |
